VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 86 filers reported holding VERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $342,614 | +490.2% | 24,990 | +590.9% | 0.00% | – |
| Q2 2023 | $58,052 | +190.1% | 3,617 | +40.2% | 0.00% | – |
| Q1 2023 | $20,013 | -82.5% | 2,579 | -56.3% | 0.00% | – |
| Q4 2022 | $114,282 | +0.2% | 5,906 | +9.7% | 0.00% | – |
| Q3 2022 | $114,000 | +70.1% | 5,386 | +10.0% | 0.00% | – |
| Q2 2022 | $67,000 | +116.1% | 4,898 | +274.8% | 0.00% | – |
| Q1 2022 | $31,000 | +24.0% | 1,307 | +40.1% | 0.00% | – |
| Q4 2021 | $25,000 | +108.3% | 933 | +40.9% | 0.00% | – |
| Q3 2021 | $12,000 | – | 662 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $40,289,000 | 12.90% |
| Kynam Capital Management, LP | 1,522,712 | $20,724,000 | 5.29% |
| Sofinnova Investments, Inc. | 3,181,442 | $43,299,000 | 3.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,825 | $281,057,000 | 2.93% |
| Octagon Capital Advisors LP | 575,000 | $7,826,000 | 2.09% |
| Vivo Capital, LLC | 666,666 | $9,073,000 | 0.91% |
| RA Capital Management | 1,578,820 | $21,488,000 | 0.57% |
| Alphabet Inc. | 301,580 | $4,105,000 | 0.22% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $219,000 | 0.11% |
| Polar Asset Management Partners Inc. | 294,300 | $4,005,000 | 0.05% |